Published regulatory strategy
ER-100 Publicly Confirmed Development Program - ER-100 (AAV2-OSK epigenetic therapy) - Optic neuropathies: open-angle glaucoma (OAG) and non-arteritic anterior ischemic optic neuropathy (NAION)
ER-100 (AAV2-OSK epigenetic therapy) · Optic neuropathies: open-angle glaucoma (OAG) and non-arteritic anterior ischemic optic neuropathy (NAION)
Published snapshot · read only · drag elements vertically to inspect the layout
›
Workstream / schedule object
2023
2024
2025
2026
2027
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Today
Navigator